Targeting and sensitizing MDR cancer by an MMP2 and pH dual-responsive ZnO-based nanomedicine
The main extra consideration is that MT-II should not be used during pregnancy or breastfeeding due to insufficient safety data
Research focuses on how GHK-Cu upregulates the gene expression of collagen type I, collagen type III, elastin, and proteoglycans within dermal fibroblasts, promoting structural tissue density and resilience
Do not take this product if taking the following medications: 5-fluorouracil, ACE inhibitors, activated charcoal, aminoglycoside antibiotics, amiodarone, antacids, anticoagulants/antiplatelet drugs, antidiabetic drugs, antihypertensive drugs, atazanavir, bisphosphonates, blood thinners, calcium channel blockers, capecitabine, cephalexin, chloroquine, cisplatin, digoxin, fosphenytoin, integrase inhibitors, levodopa/carbidopa, methotrexate, nitroglycerin, phenobarbital, penicillamine, phenytoin, potassium-sparing diuretics, primidone, pyrimethamine, quinolone antibiotics, ritonavir, skeletal muscle relaxants, sulfonylureas, and/or tetracycline antibiotics
Its also helpful to select a product thats third-party tested for purity and potency